Research News
BrightFocus is funding a clinical trial to try to fight glaucoma with a new drug implanted in the eye that may protect the optic nerve.
The week of July 20-24, 2014 brought the International Society for Eye Research (ISER) biennial meeting to U.S. shores. In San Francisco, ISER 2014 drew 800 scientists from 37 countries to hear about the latest in vision research.
Optical coherence tomography (OCT), magnetic resonance imaging (MRI), and other techniques are improving our ability to look deep inside the eye. Thanks to National Glaucoma Research funding, BrightFocus researchers are among those who have advanced new imaging methods, taking them from experimental stages to their new threshold, where they wait to become standard as clinical tools.
After years spent researching a protein linked to inherited forms of glaucoma, Raquel Lieberman, PhD, and her team at Georgia Tech have provided a three-dimensional view of that protein and a better understanding of what can happen when it becomes misshapen through genetic miscoding.